CompletedNCT00716755
Lower antipsychotic doses and brain imaging in older adults with psychosis
About this title
Read the official source — NCT00716755Medication studyAges 50+CanadaSchizophrenia
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria applied.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateOctober 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 45
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- Over 50 Years
- Official registry ID
- NCT00716755
- Official title
Show the full official title
The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Risperidone/Olanzapine and PET scans.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria applied.
